WVXU: Concern over PFAS in our water may not be over

UC scientist discusses drinking water pollutants

REPLACE WITH YOUR TEXT. Right click, and then click the pen-shaped icon.

Aliquam erat volutpat. Nunc vitae neque odio. Morbi diam lacus, lacinia et consequat nec, sagittis ac mauris. Etiam consectetur sed ipsum eget ornare. Aliquam imperdiet, massa non tincidunt faucibus, elit tortor tincidunt ante, ut semper lectus sapien vel arcu. Suspendisse in dictum metus, sit amet semper odio. Vivamus varius libero sit amet elit imperdiet finibus.

Related Stories

2

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.